Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;27(4):1213-24.
doi: 10.1681/ASN.2015020114. Epub 2015 Aug 10.

Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN

Collaborators, Affiliations

Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN

Mohamad Zaidan et al. J Am Soc Nephrol. 2016 Apr.

Abstract

Noninfectious mixed cryoglobulinemic GN (MCGN) has been poorly investigated. We analyzed presentation and outcome of 80 patients with biopsy-proven MCGN, which were identified in the retrospective French CryoVas survey. MCGN was related to primary Sjögren's syndrome in 22.5% of patients and to lymphoproliferative disorders in 28.7% of patients, and was defined as essential in 48.8% of patients. At presentation, hematuria, proteinuria ≥1 g/d, hypertension, and renal failure were observed in 97.4%, 84.8%, 85.3%, and 82.3% of cases, respectively. Mean±eGFR was 39.5±20.4 ml/min per 1.73 m(2) Membranoproliferative GN was the predominant histologic pattern, observed in 89.6% of cases. Renal interstitium inflammatory infiltrates were observed in 50% of cases. First-line treatment consisted of steroids alone (27.6%) or in association with rituximab (21.1%), alkylating agents (36.8%) or a combination of cyclophosphamide and rituximab (10.5%). After a mean follow-up of 49.9±45.5 months, 42.7% of patients relapsed with a renal flare in 75% of cases. At last follow-up, mean eGFR was 50.2±26.1 ml/min per 1.73 m(2)with 9% of patients having reached ESRD; 59% and 50% of patients achieved complete clinical and renal remission, respectively. A rituximab+steroids regimen prevented relapses more effectively than steroids alone or a cyclophosphamide+steroids combination did, but was associated with a higher rate of early death when used as first-line therapy. Severe infections and new-onset B-cell lymphoma occurred in 29.1% and 8.9% of cases, respectively; 24% of patients died. In conclusion, noninfectious MCGN has a poor long-term outcome with severe infections as the main cause of death.

Keywords: histopathology,; membranoproliferative GN.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Glomerular lesions in the course of noninfectious MCV. Light microscopy examination showing typical MPGN with endocapillary proliferation, capillary lumen infiltration by monocytes–macrophages, and Ig-related protein thrombi in the capillary lumen (A, Masson’s trichrome stain, ×400), typical doubles contours (B, Jones’ staining, ×400) and a case of mesangial proliferative GN (C, Masson’s trichrome stain, ×400). Immunofluorescence study showing granular and immune-complex glomerular deposits composed of IgG (D). IgM, and both κ and λ light chains were also detected in a similar pattern (data not shown). Electron microscopy analysis showing capillary thickening and subendothelial granular dense deposits (E; Po, podocyte; Ec, endothelial cell; Rbc, red blood cell; *, dense deposits), and organized microtubular deposits (F).

References

    1. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M: Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57: 775–788, 1974 - PubMed
    1. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327: 1490–1495, 1992 - PubMed
    1. Abel G, Zhang QX, Agnello V: Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 36: 1341–1349, 1993 - PubMed
    1. Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, Leger JM, Huraux JM, Piette JC, Godeau P: Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96: 124–132, 1994 - PubMed
    1. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P: Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 42: 2204–2212, 1999 - PubMed

MeSH terms